Roy Himadri, Bhardwaj Shalini, Ylä-Herttuala Seppo
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Kuopio, P.O. Box 1627, FIN-70211, Kuopio, Finland.
FEBS Lett. 2006 May 22;580(12):2879-87. doi: 10.1016/j.febslet.2006.03.087. Epub 2006 Apr 17.
Angiogenesis is the process by which new blood vessels are formed from existing vessels. The vascular endothelial growth factors (VEGFs) are considered as key molecules in the process of angiogenesis. The VEGF family currently includes VEGF-A, -B, -C, -D, -E, -F and placenta growth factor (PlGF), that bind in a distinct pattern to three structurally related receptor tyrosine kinases, denoted VEGF receptor-1, -2, and -3. VEGF-C and VEGF-D also play a crucial role in the process of lymphangiogenesis. Here, we review the biology of VEGFs and evaluate their role in pathological angiogenesis and lymphangiogenesis.
血管生成是指从现有血管形成新血管的过程。血管内皮生长因子(VEGF)被认为是血管生成过程中的关键分子。VEGF家族目前包括VEGF-A、-B、-C、-D、-E、-F和胎盘生长因子(PlGF),它们以独特的模式与三种结构相关的受体酪氨酸激酶结合,分别称为VEGF受体-1、-2和-3。VEGF-C和VEGF-D在淋巴管生成过程中也起着关键作用。在此,我们综述VEGF的生物学特性,并评估它们在病理性血管生成和淋巴管生成中的作用。